CIM-301

N/A

Report date: 2025/01/26 17:26:37

Base Information

Drug NameCIM-301

Drug Alias NameCIM-301

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapyBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionNatural killer cells modulators

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCimaas Bv

China Registration ClassN/A

Develop Information

Active CompaniesCimaas Bv

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A